Literature DB >> 7117754

Effects of BCG and cyclophosphamide on the spontaneous and antibody-dependent cell-mediated cytotoxicity of peritoneal and spleen lymphocytes of ACI/N rats.

N Saijo, N Irimajiri, A Ozaki, T Takizawa, Y Beppu, M Shibuya, E Shimizu.   

Abstract

The effects of BCG and cyclophosphamide on the antibody-dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) activity of spleen and peritoneal lymphocytes were serially examined after treatment. The changes of ADCC and NK activity were different in peritoneal and spleen lymphocytes according to the route and timing of administration. The decrease of NK activity induced by cyclophosphamide is not marked, and the degree of decrease depends on the timing of cyclophosphamide administration. The ADCC and NK activity of peritoneal lymphocytes after intravenous BCG administration were elevated 7 days after treatment, but the NK activity of spleen lymphocytes was decreased. On the other hand, the NK activities of peritoneal and spleen lymphocytes were elevated in rats given intraperitoneal BCG. Spleen lymphocytes and peritoneal lymphocytes from rats given intravenous BCG suppressed tumor growth in the Winn test during the early tumor-bearing stage. The spleen lymphocytes with low NK activity in rats given intravenous BCG strongly suppressed the NK activity of normal spleen lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117754

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  4 in total

Review 1.  NK cell-based immunotherapies in Pediatric Oncology.

Authors:  Kimberly A McDowell; Jacquelyn A Hank; Kenneth B DeSantes; Christian M Capitini; Mario Otto; Paul M Sondel
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

2.  Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.

Authors:  N Saijo; A Ozaki; Y Beppu; K Takahashi; J Fujita; Y Sasaki; H Nomori; M Kimata; E Shimizu; A Hoshi
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.

Authors:  K Takahashi; N Saijo; M Kimata; Y Sasaki; J Fujita; H Futami; E Shimizu; K Eguchi; T Shinkai; K Tominaga
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

4.  Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

Authors:  N Saijo; E Shimizu; M Shibuya; N Irimajiri; T Takizawa; K Eguchi; T Shinkai; K Tominaga; Z Shimabukuro; T Taniguchi; A Hoshi
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.